Clinical Trial

Testing Experimental Medication in Healthy Subjects

Study Description

A Study of LY3556050 in Healthy Participants

The main purpose of this study is to learn more about the safety of LY3556050 after it is given by mouth to healthy participants. Blood tests will be performed to check how much LY3556050 gets into the bloodstream and how long the body takes to get rid of it. Each enrolled participant will receive multiple doses of LY3556050 or placebo and will remain in the study for up to 31 days.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - LY3556050

Administered orally.

Drug - Placebo

Administered orally.

Drug - Iohexol

Administered IV.

Drug - Metformin

Administered orally.

Additional Information

Official Study Title

Multiple-Ascending Dose, Safety, Tolerability, and Pharmacokinetic Study With LY3556050 in Healthy Subjects

Clinical Trial ID

NCT04156750

ParticipAid ID

aM843e